Our expert panels

International Advisory Panel

The ACE International Advisory Panel (IAP) comprises international experts who advise ACE on health technology assessments (HTA), healthcare guideline development, and education to support informed decision-making in patient care, drawing on global perspectives and international best practices. Members serve a three-year term from 1 Mar 2026 to 28 Feb 2029.

Current IAP Members

Prof Robyn Ward

• Deputy Vice-Chancellor (Research and Enterprise) and Senior Vice-President, Monash University, Australia

• Chair, Commonwealth Pharmaceutical Benefits Advisory Committee (PBAC)

Prof Jonathan Benger

• Chief Executive, National Institute for Health and Care Excellence (NICE), United Kingdom

Ms Sudha Kutty

• Executive Vice-President, Evidence, Products, and Services, Canada’s Drug Agency (CDA-AMC), Canada

Ms Natalie McMurtry

• Chief Executive, Pharmaceutical Management Agency (Pharmac), New Zealand

Assoc Prof Sarah Norris

• Associate Professor of Health Technology Assessment, School of Public Health, The University of Sydney, Australia

• Co-Deputy Chair, Commonwealth Medical Services Advisory Committee (MSAC)

• Chair, MSAC Evaluation Subcommittee

Dr Sarah Byon

• Programme Director, HealthTech Strategy and Development, National Institute for Health and Care Excellence (NICE), United Kingdom

Prof Dawn Craig

• Professor of Evidence Synthesis, Newcastle University, United Kingdom

• Director, National Institute for Health and Care Research (NIHR) Innovation Observatory, United Kingdom

Prof Holger Schünemann

• Professor, Clinical Epidemiology and Research Center, Humanitas University, Italy

• Chair, GRADE Working Group

• Professor Emeritus, Clinical Epidemiology and Medicine, McMaster University, Canada

Prof Zachary Munn

• Director, Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, The University of Adelaide, Australia

• Director, Adelaide GRADE Centre

Prof Natalie Taylor

• Director, Implementation to Impact (i2i), University of New South Wales, Sydney, Australia

Prof Sally Lewis

• Professor of Value in Health Management, Value-Based Health and Care Academy, School of Management, Swansea University, United Kingdom

• Director, Kintsugi International and Radical Value Alliance

Prof Paul Bastiaan van der Nat

• Chief Value Officer, St. Antonius Hospital, The Netherlands

• Professor, Value-Based Healthcare, IQ Health, Radboudumc, The Netherland

• Research Development Manager, Santeon, The Netherlands

• Founder and Chair, Value Catalyst Learning Community

Prof Mark Sculpher

• Professor of Health Economics, Centre for Health Economics, University of York, United Kingdom

Prof Nicholas Latimer

• Professor of Health Economics, Sheffield Centre for Health and Related Research, The University of Sheffield, United Kingdom

• Co-lead, National Institute for Health and Care Excellence (NICE) Decision Support Unit

Prof Mark Jit

• Professor and Chair of the Department of Global and Environmental Health, New York University, United States

ACE Consumer Panel

The ACE Consumer Panel supports meaningful patient involvement across ACE’s work and other Ministry of Health (MOH) initiatives supported by ACE, and informs the development of consumer engagement and education initiatives. The Panel comprises individuals from local patient organisations, and leaders of patient engagement efforts in the healthcare clusters or academic institutions who have extensive lived experiences engaging with the Singapore healthcare system. Current Panel members have been appointed for a 2-year term from 1 Apr 2026 to 31 Mar 2028.

ACE Consumer Panel Members

Mr Ellil Mathiyan Lakshmanan

(Chair)

• President, Ostomy Association of Sing

• Co-Chair, SingHealth Patient Advocacy Network

• Interim Vice President, Asia and South Pacific Ostomy Association (ASPOA)

 Hj Sallim Abdul Kadir

• Board Member, Alliance of Patients’ Organizations Singapore

• Board Member, Cerebral Palsy Alliance of Singapore

Dr Dennis Chia

• Group Director, Clinical Services, Singapore Cancer Society

• Adjunct Lecturer, Saw Swee Hock School of Public Health, NUS

 Ms Candy Gan

• Type 1 Diabetes Advocate, typeOne.sg, Diabetes Singapore

• OPEN Voices Patient Partner, Lee Kong Chian School of Medicine, NTU

• Assistant Chief Executive Office, NUHS

Ms Tracy Gan

• Director, Service Leadership & Patient Relations and Volunteer Corporate Office, NHG Polyclinics

• Admin Lead, Patient Advisory Councils, NHG Polyclinics

 Dr Ritu Jain

• President, Dystrophic Epidermolysis Bullosa Research Association (DEBRA) Singapore

• Assistant Chair, School of Humanities, NTU

• Senior Lecturer (courtesy appointment), Lee Kong Chian School of Medicine, NTU

 Adjunct Professor Lau Tang Ching

• Senior Consultant, Division of Rheumatology and Allergy, Department of Medicine, NUH

• Vice-Dean (Education), Yong Loo Lin School of Medicine, NUS

• Group Director, Education Office, NUHS

 Ms Melissa Lim

• President, Brain Tumour Society (Singapore)

• Chairperson, Asia Pacific Brain Tumour Alliance

• Patient Advocate, SingHealth Patient Advocacy Network

 Ms Ai Ling Sim-Devadas

• Deputy Director, Office of Patient Engagement (OPEN), Lee Kong Chian School of Medicine, NTU

Mr Teng Chiun How

• Senior Director, Singapore Heart Foundation